Literature DB >> 6893455

Identification of membrane proteins mediating the interaction of human platelets.

D R Phillips, L K Jennings, H H Edwards.   

Abstract

Membrane glycoproteins that mediate platelet-platelet interactions were investigated by identifying those associated with the cytoskeletal structures from aggregated platelets. The cytoskeletal structures from washed platelets, thrombin-activated platelets (platelets incubated with thrombin in the presence of mM EDTA to prevent aggregation) and thrombin- aggregated platelets (platelets activated in the presence of mM Ca(++) were prepared by first treating platelet suspensions with 1 percent Triton X-100 and 5 mM EGTA and then isolating the insoluble residue by centrifugation. The readily identifiable structures in electron micrographs of the residue from washed platelets had the shape and dimensions of actin filaments. Analysis of this residue from washed platelets had the shape and dimensions of actin filaments. Analysis of this residue by SDS gel electrophoresis showed that it consisted primarily of three proteins: actin (mol wt = 43,000), myosin (mol wt = 200,000) and a high molecular weight polypeptide (mol wt = 255,000) which had properties indentical to actin-binding protein (filamin). When platelets are activated with thrombin in the presence of EDTA to prevent aggregation, there was a marked increase in the amount of insoluble precipitate in the subsequent Triton extraction. Transmission electron microscopy showed that this residue not only contained the random array of actin filaments as seen above, but also organized structures from individual platelets which appeared as balls of electron-dense filamentous material approximately 1mum in diameter. SDS polyacrylamide gel analysis of the Triton residue of activated platelets showed that this preparation contained more actin, myosin and actin-binding protein than that from washed platelets plus polypeptides with mol wt of 56,000 and 90,000 and other minor polypeptides. Thus, thrombin activation appeared to increase polymerization of actin in association with other cytoskeletal proteins into structures that are observable after Triton extraction. The cytoskeletal structures from thrombin-aggregated platelets were similar to those from thrombin-activated platelets, except that the structural elements from individual platelets remained aggregated rather than randomly dispersed in the actin filaments. This suggested that the membrane components that mediate the direct interaction of platelets were in Triton residue from aggregated platelets. Only a small percentage of the membrane surface proteins and glycoproteins were found in the cytoskeletal structures from either washed platelets or thrombin-activated platelets. In contrast, the aggregated cytoskeletal structures from thrombin-aggregated platelets contained membrane glycoproteins IIb (26 percent of the total in pre-extracted platelets) and III (14 percent), suggesting that one or both of these glycoproteins participate in the direct interaction of platelets during aggregation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893455      PMCID: PMC2110644          DOI: 10.1083/jcb.86.1.77

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  52 in total

1.  A simple technique for eliminating interference by detergents in the Lowry method of protein determination.

Authors:  J R Dulley; P A Grieve
Journal:  Anal Biochem       Date:  1975-03       Impact factor: 3.365

2.  ELECTRON MICROSCOPE STUDIES ON THE STRUCTURE OF NATURAL AND SYNTHETIC PROTEIN FILAMENTS FROM STRIATED MUSCLE.

Authors:  H E HUXLEY
Journal:  J Mol Biol       Date:  1963-09       Impact factor: 5.469

3.  Surface glycoproteins of human white blood cells. Analysis by surface labeling.

Authors:  L C Andersson; C G Gahmberg
Journal:  Blood       Date:  1978-07       Impact factor: 22.113

4.  Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface.

Authors:  T Okumura; M Hasitz; G A Jamieson
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  An association between actin and the major histocompatibility antigen H-2.

Authors:  G L Koch; M J Smith
Journal:  Nature       Date:  1978-05-25       Impact factor: 49.962

7.  Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis.

Authors:  D R Phillips; P P Agin
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

8.  Interaction of filamin with f-actin in solution.

Authors:  K Wang; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

9.  Actin is the naturally occurring inhibitor of deoxyribonuclease I.

Authors:  E Lazarides; U Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

10.  Interactions of actin, myosin, and a new actin-binding protein of rabbit pulmonary macrophages. II. Role in cytoplasmic movement and phagocytosis.

Authors:  T P Stossel; J H Hartwig
Journal:  J Cell Biol       Date:  1976-03       Impact factor: 10.539

View more
  77 in total

1.  Calcium-dependent properties of CIB binding to the integrin alphaIIb cytoplasmic domain and translocation to the platelet cytoskeleton.

Authors:  D D Shock; U P Naik; J E Brittain; S K Alahari; J Sondek; L V Parise
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

2.  Naturally occurring human IgG antibodies to intracellular and cytoskeletal components of human platelets.

Authors:  S L Pfueller; D Logan; T T Tran; R A Bilston
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

3.  Aggregation-related association of lipid with the cytoskeleton of rabbit and human platelets prelabeled with [3H]palmitic acid. Similar effects of adenosine diphosphate- and thrombin-induced aggregation.

Authors:  A Livne; M A Packham; M A Guccione; J F Mustard
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  Imaging thrombus with radiolabelled monoclonal antibody to platelets.

Authors:  A M Peters; J P Lavender; S G Needham; I Loutfi; D Snook; A A Epenetos; P Lumley; R J Keery; N Hogg
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

5.  Ligands to the platelet fibrinogen receptor glycoprotein IIb-IIIa do not affect agonist-induced second messengers Ca2+ or cyclic AMP.

Authors:  J A Williams; B Ashby; J L Daniel
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

6.  An alternative cytoplasmic domain of the integrin beta 3 subunit.

Authors:  T H van Kuppevelt; L R Languino; J O Gailit; S Suzuki; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures.

Authors:  K M Pumiglia; M B Feinstein
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

8.  Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton.

Authors:  M Torti; G Ramaschi; F Sinigaglia; E G Lapetina; C Balduini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  Redistribution of activated pp60c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets.

Authors:  E A Clark; J S Brugge
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

10.  Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons.

Authors:  M E Wheeler; A C Cox; R C Carroll
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.